Literature DB >> 32079438

Mesenchymal stromal cells administration for osteonecrosis of the jaw caused by bisphosphonate: report of two cases.

Gil Cunha De Santis1, Leandro Dorigan de Macedo2, Maristela Delgado Orellana1, Lara Maria Alencar Ramos Innocentini2, Tatiane Cristina Ferrari2, Hilton Marcos Alves Ricz2, Sâmia Rigotto Caruso1, Taísa Risque Fernandes1, Dimas Tadeu Covas1,3.   

Abstract

Entities:  

Year:  2020        PMID： 32079438     DOI： 10.1080/0284186X.2020.1730004

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  3 in total

Review 1.  Novel Cell Therapy Using Mesenchymal Stromal Cell Sheets for Medication-Related Osteonecrosis of the Jaw.

Authors:  Nobuyuki Kaibuchi; Takanori Iwata; Yoko Kawase Koga; Toshihiro Okamoto
Journal:  Front Bioeng Biotechnol       Date:  2022-05-12

2.  The Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review with a Pooled Analysis of Only Surgery versus Combined Protocols.

Authors:  Olga Di Fede; Federica Canepa; Vera Panzarella; Rodolfo Mauceri; Carmine Del Gaizo; Alberto Bedogni; Vittorio Fusco; Pietro Tozzo; Giuseppe Pizzo; Giuseppina Campisi; Antonio Galvano
Journal:  Int J Environ Res Public Health       Date:  2021-08-10       Impact factor: 3.390

Review 3.  Various Therapeutic Methods for the Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ) and Their Limitations: A Narrative Review on New Molecular and Cellular Therapeutic Approaches.

Authors:  Sung-Woon On; Seoung-Won Cho; Soo-Hwan Byun; Byoung-Eun Yang
Journal:  Antioxidants (Basel)       Date:  2021-04-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.